Topic: COVID-19 vaccines

The Short Report – March 17, 2021: Canadian government invests heavily to bolster biomanufacturing, D-Wave Systems gets funding for quantum tech, Canada’s largest study on aging gets a top-up, and more

The Government of Canada seeks to bolster Canada’s biomanufacturing capacity, D-Wave receives $40 million to accelerate Canada’s quantum technology development, the federal government invests in Canada’s longest-ever study on aging, Quebec’s Lion Electric gets ready to break ground on a new battery manufacturing plant, and more.

Calgary vaccine developer reaches deal with Manitoba government after hearing no response from Ottawa

Providence Therapeutics, a Calgary biotechnology company in human trials with its COVID-19 vaccine, struck a supply deal with the Government of Manitoba after sending the federal government a proposal and receiving no response. In a video, Providence founder and CEO Brad Sorenson criticized Ottawa’s “apathetic response” as “unacceptable” and he implored the government to take initiative to establish a secure domestic vaccine supply.

NGen joins $10-million effort to bolster manufacturing capacity for a COVID-19 vaccine

The NGen supercluster has awarded $27 million in funding for 12 advanced manufacturing projects that can supply critical health care products to combat COVID-19. The funding includes $5 million for Providence Therapeutics and partner Northern RNA to establish manufacturing capacity in Calgary for Providence’s made-in-Canada vaccine.